Skip to main content

Table 1 Clinical characteristics of control subjects and RA patients

From: Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study

  Control (n = 17) RA (n = 23) p value RA, DMARD (n = 10) RA, anti-TNF (n = 13) p value
Sex, male/female 7/10 8/15 0.680 3/7 5/8 0.637
Age, years 58 ± 13 58 ± 9 0.894 55 ± 11 60 ± 8 0.193
Body mass index, kg/m2 22 ± 2 26 ± 6 0.005 25 ± 6 26 ± 4 0.368
Smoking, yes/no 0/17 8/23 0.022 3/7 4/13 0.708
SBP, mmHg 127 ± 13 143 ± 23 0.014 131 ± 22 151 ± 20 0.028
DPB, mmHg 78 ± 8 87 ± 15 0.036 83 ± 15 90 ± 14 0.270
Total cholesterol, mmol/L 5.4 ± 0.9 5.4 ± 0.9 1.000 5.3 ± 0.9 5.4 ± 0.9 0.613
LDL cholesterol, mmol/L 3.3 ± 0.9 3.6 ± 1.1 0.396 3.4 ± 0.8 3.7 ± 1.3 0.284
HDL cholesterol, mmol/L 1.7 ± 0.4 1.5 ± 0.5 0.135 1.6 ± 0.5 1.4 ± 0.4 0.152
Triglycerides, mmol/L 0.66[0.5–1.0] 1.2[0.9–1.8] 0.001 1.1[0.9–1.4] 1.3[0.9–2.1] 0.393
CRP, mg/L 13[7–16] 18[13–30] 0.022 16[12–48] 19[14–30] 0.888
  1. Values are n (%), mean ± SD or median [IQR,] for skewed data
  2. RA rheumatoid arthritis, DMARD disease-modifying antirheumatic drug, TNF tumor necrosis factor, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low-density lipoprotein, HDL high-density lipoprotein, CRP C-reactive protein